TABLE 1

Characteristics of interleukin (IL)-6 trans-signalling (IL-6TS)-high subjects with COPD (BEAT-COPD (Biomarkers to Target Antibiotic and Systemic Corticosteroid Therapy in COPD Exacerbation) cohort)

IL-6TS-highIL-6TS-lowp-value
Subjects n2450
Age years69.0±1.867.8±1.40.60
Female33.328.00.75#
BMI kg·m−225.70±0.9625.04±0.630.32
Current and ex-smokers95.8396.000.97#
Pre-FEV1 L1.27±0.121.14±0.070.26
Post-FEV1 L1.29±0.121.19±0.080.46
Exacerbations in past year3 (1.5–4.0) (n=19)2 (2.0–3.0) (n=37)0.61
Daily ICS dose μg·day−11000 (500–1000) (n=18)1000 (800–1000) (n=35)0.75
Maintenance prednisolone10.53 (n=19)10.81 (n=37)0.97#
CRQ total score13.64±0.9816.72±0.630.008
CRQ mastery4.07±0.294.87±0.210.021
CRQ fatigue2.84±0.263.64±0.180.049
CRQ emotion3.74±0.324.61±0.180.088
CRQ dyspnoea2.64±0.293.06±0.190.26
Blood eosinophils ×1000·μL−10.24 (0.17–0.37)0.22 (0.13–0.39)0.32
Blood neutrophils ×1000·μL−15.35 (4.48–5.90)4.74 (4.15–5.78)0.24
Serum CRP mg·L–16.77±2.224.55±1.100.088
Serum IL-6 pg·mL–117.42±7.1812.64±3.140.024
TCC ×106 cells·g−1 sputum7.14 (4.2–15.6)2.62 (1.4–4.6) (n=49)0.0001
Sputum eosinophils %1.00 (0.3–2.5)1.75 (0.5–4.3) (n=48)0.13
Sputum neutrophils %87.13 (72.6–92.6)66.25 (44.4–81.7) (n=48)0.0004
Sputum macrophages %10.11 (5.3–19.7)25.00 (12.7–36.4) (n=48)0.002
Sputum TNF-α pg·mL–146.02±56.362.11±3.11<0.00001
Sputum MIP-1α pg·mL–1153.80±52.2744.63±0.37<0.00001
Sputum RANTES pg·mL–17.41±2.342.28±0.58<0.00001
Sputum MMP9 ng·mL–11008.79±279.40201.32±49.47<0.00001
Sputum MMP8 ng·mL–1736.57±229.86127.32±372.61<0.00001
Sputum MMP2 ng·mL–13.11±0.540.00±0.400.005

Data are presented as geometric mean±se, % or median (interquartile range), unless otherwise stated. Bold type represents statistical significance (p≤0.05). p-values by Kruskal–Wallis test. BMI: body mass index; FEV1: forced expiratory volume in 1s; ICS: inhaled corticosteroid; CRQ: Chronic Respiratory Questionnaire; CRP: C-reactive protein; TCC: total sputum cell count; TNF: tumour necrosis factor; MIP: macrophage inflammatory protein; MMP: matrix metalloproteinase. #: Chi-squared test.